Evidence map›Paper›PMID 34082707›Full record

ArticleBMC bioinformatics2021

RNAdetector: a free user-friendly stand-alone and cloud-based system for RNA-Seq data analysis.

Alessandro La Ferlita, Salvatore Alaimo, Sebastiano Di Bella, Emanuele Martorana, Georgios I Laliotis, Francesco Bertoni, Luciano Cascione, Philip N Tsichlis, Alfredo Ferro, Roberta Bosotti and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Exploring the Role ofACS infectious diseases · 2026
    Article
  2. Article
  3. Gut microbes · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Alessandro La Ferlita *Department of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy.
Salvatore Alaimo *Department of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy.
Sebastiano Di BellaNerviano Medical Sciences, Nerviano, Milan, Italy.
Emanuele MartoranaRegional Referral Centre for Rare Lung Diseases, A. O. U. "Policlinico-Vittorio Emanuele", Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Georgios I LaliotisDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Francesco BertoniInstitute of Oncology Research, Bellinzona, Switzerland.
Luciano CascioneInstitute of Oncology Research, Bellinzona, Switzerland.
Philip N TsichlisDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Alfredo FerroDepartment of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy.
Roberta BosottiNerviano Medical Sciences, Nerviano, Milan, Italy.
Alfredo PulvirentiDepartment of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy. alfredo.pulvirenti@unict.it.ORCID http://orcid.org/0000-0002-9764-0295
University of Catania · ITInstitute of Oncology Research · CHNerviano Medical Sciences · ITThe Ohio State University · US

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca B96G18000590005PO-FESR Sicilia 14-20 G89J18000700007
6 · The paper itself

Abstract

backgroundRNA-Seq is a well-established technology extensively used for transcriptome profiling, allowing the analysis of coding and non-coding RNA molecules. However, this technology produces a vast amount of data requiring sophisticated computational approaches for their analysis than other traditional technologies such as Real-Time PCR or microarrays, strongly discouraging non-expert users. For this reason, dozens of pipelines have been deployed for the analysis of RNA-Seq data. Although interesting, these present several limitations and their usage require a technical background, which may be uncommon in small research laboratories. Therefore, the application of these technologies in such contexts is still limited and causes a clear bottleneck in knowledge advancement.

resultsMotivated by these considerations, we have developed RNAdetector, a new free cross-platform and user-friendly RNA-Seq data analysis software that can be used locally or in cloud environments through an easy-to-use Graphical User Interface allowing the analysis of coding and non-coding RNAs from RNA-Seq datasets of any sequenced biological species.

conclusionsRNAdetector is a new software that fills an essential gap between the needs of biomedical and research labs to process RNA-Seq data and their common lack of technical background in performing such analysis, which usually relies on outsourcing such steps to third party bioinformatics facilities or using expensive commercial software.

Indexed as

Cloud ComputingData AnalysisComputational BiologyHigh-Throughput Nucleotide SequencingRNA-SeqSequence Analysis, RNASoftwareCloud deploymentDifferential expression analysisDockerncRNAsPathway analysisPipelineRNA-seqStand-alone software

Identifiers

PMID34082707
PMCPMC8173825
OpenAlexW3164934299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.